At Lantheus, we Find, Fight and Follow® disease to improve outcomes and lives. We are the leading radiopharmaceutical-focused company with proven expertise in developing, manufacturing and commercializing cutting-edge radiodiagnostics. We understand that patients deserve more—more clarity when receiving a diagnosis and more options to treat disease – and we are committed to following the science across multiple targets in our efforts to develop groundbreaking radioligand therapies and radiodiagnostic tracers, focusing on prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR).

• Facing Prostate Cancer with Strength and Hope - Men Share Their Stories
• Life After Prostate Cancer - Real Men, Real Stories, Real Inspiration